![Heng Liu](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Heng Liu
Plus aucun poste en cours
Fortune : 180 M $ au 30/09/2026
Profil
Dr. Heng Liu is a Chairman & General Manager at LongBio Pharma (Suzhou) Co., Ltd. Dr. Liu was previously employed as a Deputy Director-Pre Clinical Research by Evive Biotechnology (Shanghai Ltd. and a Co-Founder by Pharmab, Inc. He received his undergraduate degree from Shenyang Pharmaceutical University and a doctorate degree from The State University of New York.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
17,78% | 06/07/2026 | 13 347 056 ( 17,78% ) | 180 M $ | 30/09/2026 |
Postes actifs de Heng Liu
| Sociétés | Poste | Début |
|---|
Anciens postes connus de Heng Liu
| Sociétés | Poste | Fin |
|---|
Formation de Heng Liu
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
56
Relations au 1er degré
2
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 2 |
|---|---|
The State University of New York
 The State University of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Shenyang Pharmaceutical University
 Shenyang Pharmaceutical University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
